542 results on '"Angelillo-Scherrer, Anne"'
Search Results
2. Thrombophilia and outcomes of venous thromboembolism in older patients
3. Unstable hemoglobin Montreal II uncovered in an adult with unexplained hemolysis exacerbated by a presumed viral infection: a case report
4. The potential impact of Covid-19 on the capacity of routine laboratory tests to detect heparin-induced thrombocytopenia
5. Humoral and cellular responses to mRNA vaccines against SARS-CoV-2 in patients with a history of CD20 B-cell-depleting therapy (RituxiVac): an investigator-initiated, single-centre, open-label study
6. Resistance to thrombomodulin correlates with liver stiffness in chronic liver disease a prospective single-center cohort study
7. ATG5 promotes eosinopoiesis but inhibits eosinophil effector functions
8. Platelet protein S limits venous but not arterial thrombosis propensity by controlling coagulation in the thrombus
9. Ribonuclease Inhibitor and Angiogenin collaboratively regulate cell-type-specific global translation
10. Accuracy of heparin-induced platelet aggregation test for the diagnosis of heparin-induced thrombocytopenia
11. Thrombin generation measurement using the ST Genesia Thrombin Generation System in a cohort of healthy adults: Normal values and variability
12. Supplementary Data1 from Development of Resistance to Type II JAK2 Inhibitors in MPN Depends on AXL Kinase and Is Targetable
13. Data from Development of Resistance to Type II JAK2 Inhibitors in MPN Depends on AXL Kinase and Is Targetable
14. A high Gas6 level in plasma predicts venous thromboembolism recurrence, major bleeding and mortality in the elderly: a prospective multicenter cohort study
15. Gut microbiota-dependent trimethylamine-N-oxide (TMAO) shows a U-shaped association with mortality but not with recurrent venous thromboembolism
16. Genetic alterations crossing the borders of distinct hematopoetic lineages and solid tumors: Diagnostic challenges in the era of high-throughput sequencing in hemato-oncology
17. Targeting anticoagulant protein S to improve hemostasis in hemophilia
18. Development of resistance to type II JAK2 inhibitors in MPN depends on AXL kinase and is targetable
19. Thrombin Generation Is Associated with Venous Thromboembolism Recurrence, but Not with Major Bleeding and Death in the Elderly: A Prospective Multicenter Cohort Study
20. Impact of rivaroxaban on point-of-care assays
21. Acquired hemophilia A and plasma cell neoplasms: a case report and review of the literature
22. Cyclic peptide FXII inhibitor provides safe anticoagulation in a thrombosis model and in artificial lungs
23. Predictors and Causes of Long-Term Mortality in Elderly Patients with Acute Venous Thromboembolism: A Prospective Cohort Study
24. Ribonuclease inhibitor 1 regulates erythropoiesis by controlling GATA1 translation
25. Jüngste Entwicklungen in der Hämatologie, Teil 2
26. Développements récents en hématologie, Partie 2
27. Développements récents en hématologie, Teil 1
28. Jüngste Entwicklungen in der Hämatologie, Teil 1
29. PB2574: HEMOPHAGOCYTIC SYNDROME IN ADULTS - REAL-WORLD DATA ON MORTALITY FROM A TERTIARY REFERENCE CENTER
30. S209: TARGETING THE SRC HOMOLOGY 2 DOMAIN-CONTAINING PHOSPHATASE SHP2 ENHANCES THE THERAPEUTIC EFFICACY OF JAK INHIBITION IN MYELOPROLIFERATIVE NEOPLASMS
31. Thrombin Generation is Associated with Venous Thrombo-embolism Recurrence, but not with Major Bleeding and Death in the Elderly: A Prospective Multicenter Cohort Study
32. The Gas6-Axl Protein Interaction Mediates Endothelial Uptake of Platelet Microparticles
33. Antiplatelet Therapy and Anticoagulation
34. Acquired Hemostatic Disorders
35. Alternatively spliced tissue factor levels are elevated in the plasma of patients with chronic liver diseases
36. Recommendations for the use of andexanet alfa in the management of bleeding in patients on oral factor Xa inhibitors in Switzerland: Guideline from the Working Party Hemostasis of the Swiss Society of Hematology
37. Thrombin Generation Is Associated with Venous Thromboembolism Recurrence, but Not with Major Bleeding and Death in the Elderly: A Prospective Multicenter Cohort Study
38. Increased Inflammasome Activation Is Associated with Aging and Chronic Myelomonocytic Leukemia Disease Severity
39. Immunothrombosis and Complement Activation Contribute to Disease Severity and Adverse Outcome in COVID-19
40. Thrombophilia and outcomes of venous thromboembolism in older patients
41. Ribosome-Associated Protein Ribonuclease Inhibitor (RNH1) Regulates Hematopoietic Specific Translation
42. SLN140 a Small Interfering RNA Targeting Protein S Improves Hemostasis Potency in Hemophilia
43. Escape from Type II JAK2 Inhibition in MPN Depends on AXL/MAPK Activation and Is Targetable
44. Ribonuclease Inhibitor 1 (RNH1) Regulates Myeloid Lineage Choice through Cyclin-Dependent Kinase 1
45. A Role of Immunothrombosis in Acquired Antibody-Mediated Thrombophilia's: Classical Complement and Neutrophil Activation in APS and HIT
46. Blood microvesicles: From proteomics to physiology
47. Predictors and Outcomes of Recurrent Venous Thromboembolism in Elderly Patients
48. Thrombophilia Impact on Treatment Decisions, Subsequent Venous or Arterial Thrombosis and Pregnancy-Related Morbidity: A Retrospective Single-Center Cohort Study
49. JAK2 Unmutated Polycythaemia—Real-World Data of 10 Years from a Tertiary Reference Hospital
50. LRR-protein RNH1 dampens the inflammasome activation and is associated with COVID-19 severity
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.